Minute Insight: Boston Scientific Walks Away From MI Tech Deal, Citing Regulatory Hurdles

 
• By Reed Miller

The Federal Trade Commission said it supports Boston Scientific’s decision to walk away from a planned $230m acquisition of Korea-based MI Tech. Boston Scientific said it could not obtain needed global regulatory approvals.

Minute Insight
• Source: Citeline/Alamy

Boston Scientific’s proposed $230m acquisition of MI Tech is not going to happen.

In June 2022, Boston Scientific announced a definitive agreement to purchase 64% of Korea-based MI Tech from Synergy Innovation for about $230m

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight